SOPHiA GENETICS (SOPH) Gains from Equity Investments (2024 - 2025)

SOPHiA GENETICS (SOPH) reported Gains from Equity Investments of $90000.0 for Q4 2025, down 13.46% on a YoY basis from $104000.0 in Q4 2024, and up 114.83% sequentially from -$607000.0 in Q3 2025.

SOPHiA GENETICS (SOPH) Gains from Equity Investments (2024 - 2025) Analysis & Trends

SOPHiA GENETICS (SOPH) has 2 years of Gains from Equity Investments data on file, last reported at $90000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Equity Investments fell 13.46% year-over-year to $90000.0; the trailing twelve-month figure through Dec 2025 stood at -$421000.0 (changed N/A YoY), and the FY2025 full-year result was -$1.9 million, down 409.46% from the prior year.
  • Gains from Equity Investments rose to $90000.0 in Q4 2025, from -$607000.0 in the prior quarter.
  • In the past five years, Gains from Equity Investments ranged from a high of $182000.0 in Q3 2024 to a low of -$607000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.68 Bn -
10 SOPHiA GENETICS 381.60 Mn 311.31 Mn 14.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 90,000.00
Dec 31, 2025 90,000.00
Sep 30, 2025 -607,000.00
Sep 30, 2025 -607,000.00
Jun 30, 2025 58,000.00
Jun 30, 2025 58,000.00
Mar 31, 2025 38,000.00
Mar 31, 2025 38,000.00
Dec 31, 2024 104,000.00
Dec 31, 2024 104,000.00
Sep 30, 2024 182,000.00
Sep 30, 2024 182,000.00
Jun 30, 2024 84,000.00
Jun 30, 2024 84,000.00